Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lipoproteins, HDL MeSH Descriptor Data 2025


MeSH Heading
Lipoproteins, HDL
Tree Number(s)
D10.532.432
D12.776.521.479
Unique ID
D008075
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008075
Annotation
hyperalphalipoproteinemia = LIPOPROTEINS, HDL /‌blood (IM) + HYPERLIPOPROTEINEMIAS (IM); hypoalphalipoproteinemia = LIPOPROTEINS, HDL /‌blood (IM) + HYPOLIPOPROTEINEMIAS (IM); familial hypoalphalipoproteinemia = TANGIER DISEASE; /‌defic: consider also HYPOLIPOPROTEINEMIAS
Scope Note
A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.
Entry Term(s)
Heavy Lipoproteins
High Density Lipoprotein
High-Density Lipoprotein
High-Density Lipoproteins
alpha-1 Lipoprotein
alpha-Lipoprotein
alpha-Lipoproteins
Registry Numbers
0
Previous Indexing
Lipoproteins (1966-1971)
See Also
Tangier Disease
Public MeSH Note
74
History Note
74(72)
Date Established
1974/01/01
Date of Entry
1999/01/01
Revision Date
2020/05/27
Lipoproteins, HDL Preferred
alpha-1 Lipoprotein Narrower
page delivered in 0.153s